Use of an aureolysin inhibitor for the treatment of inflammatory skin conditions characterised by colonisation with Staphylococcus aureus

Details for Australian Patent Application No. 2006286497 (hide)

Owner Serentis Limited

Inventors Layton, Guy Timothy; Chandler, Stephen Rupert

Agent Griffith Hack

Pub. Number AU-A-2006286497

PCT Pub. Number WO2007/025999

Priority 0517685.4 31.08.05 GB; 0613954.7 14.07.06 GB

Filing date 31 August 2006

Wipo publication date 8 March 2007

International Classifications

C07C 259/06 (2006.01) Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups

A61K 31/00 (2006.01)

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/4035 (2006.01)

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/7056 (2006.01)

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

20 March 2008 PCT application entered the National Phase

  PCT publication WO2007/025999 Priority application(s): WO2007/025999

28 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006286498-Human FVII monoclonal antibodies binding the GLA domain and use thereof

2006286489-Treatment of optic neuritis